Israel Englander’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Israel Englander’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-49,710	Closed	-$277K	–	6297
2025 Q4	$277K	Buy	+49,710	New	+$553K	﹤0.01%	5309
2024 Q1	–	Sell	-2,725	Closed	-$281K	–	6576
2023 Q4	$281K	Sell	2,725 -4,775	-64%	-$429K	﹤0.01%	4995
2023 Q3	$732K	Buy	7,500 +2,500	+50%	+$233K	﹤0.01%	4405
2023 Q2	$586K	Buy	+5,000	New	+$634K	﹤0.01%	4425

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

Israel Englander's RVPH Position: Q2 2026 in Review

Israel Englander sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 793,948 shares — an estimated $579K sold.

Israel Englander first reported a position in RVPH in Q1 2021 and held it in 14 quarters. The position peaked at $4.13M in Q4 2023. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

Israel Englander reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
Israel Englander sold 793,948 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $579K.
Israel Englander first reported a position in REVIVA PHARMA HLDGS INC in Q1 2021 and held it in 14 quarters.
Israel Englander's REVIVA PHARMA HLDGS INC position peaked at $4.13M in Q4 2023.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.